Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease
R. López-Cuevas; M. Baquero-Toledo; A. Cuevas-Jiménez; N. Martín-Ibáñez; R. Pascual-Costa; M.J. Moreno-Monedero; A. Cañada-Martínez; C. Peña-Bautista; I. Ferrer-Cairols; L. Álvarez-Sánchez; C. Cháfer-Pericás;
Neurologia. 2023;38:262-9
Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology
M. Suárez-Calvet; C. Abdelnour; D. Alcolea; M. Mendióroz-Iriarte; M. Balasa; E. Morenas-Rodríguez; A. Puig-Pijoan; P. Sánchez-Juan; A. Villarejo; R. Sánchez-Valle;
Neurologia. 2025;40:700-12
Spanish normative studies (NEURONORMA-Plus project): norms for the Wisconsin Card Sorting Test, the Modified Taylor Complex Figure, and the Ruff-Light Trail Learning Test
C. Pérez-Enríquez; G. García-Escobar; M. Florido-Santiago; J. Piqué-Candini; C. Arrondo-Elizarán; L. Grau-Guinea; B. Pereira-Cuitiño; R.M. Manero; A. Puig-Pijoan; J. Peña-Casanova; G. Sánchez-Benavides;
Neurologia. 2024;39:235-43